Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen

Journal of Cellular Biochemistry

Volumn 104, Issue 1, 2008, Pages 27-37

  Wȩsierska Ga̧dek, Józefa ^a   Klima, Anna ^a   Ranftler, Carmen ^a   Komina, Oxana ^a   Hanover, John ^b   Invernizzi, Pietro ^c   Penner, Edward ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ANA; Autoimmunity; gp210 glycoprotein; Human recombinant p62 nucleoporin; Nuclear envelope; Nuclear pore complexes; p62 nucleoporin

Indexed keywords

AUTOANTIBODY; N ACETYLGLUCOSAMINE; NUCLEOPORIN; P62 NUCLEOPORIN; P62 NUCLEOPORIN ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; ANTIGEN; DIAGNOSTIC AGENT; RECOMBINANT PROTEIN;

ADSORPTION; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; ISOTOPE LABELING; NONHUMAN; PRECIPITATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAT; BILIARY CIRRHOSIS; BLOOD; DISEASE COURSE; HOSPITALIZATION; IMMUNOLOGY;

RATTUS; TRITICUM AESTIVUM;

ANTIGENS; AUTOANTIBODIES; DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS, BILIARY; NUCLEAR PORE COMPLEX PROTEINS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 46449135226     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21595     Document Type: Article

References (34)

1. Carmo-Fonseca M, Kern H, Hurt EC. 1991. Human nucleoporin p62 and the essential yeast nuclear pore protein NSP1 show sequence homology and a similar domain organization. Eur J Cell Biol 55:17-30.
2. Courvalin J-C, Lassoued K, Bartnik E, Blobel G, Wozniak RW. 1990a. The 210-kDa nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Inv 86:279-285.
3. Courvalin J-C, Lassoued K, Worman HJ, et al. 1990b. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 172:961-967.
4. Davis LI, Blobel G. 1987. Nuclear pore complex contains a family of glycoproteins that includes p62: Glycosylation through a previously unidentified cellular pathway. Proc Natl Acad Sci U S A 84:7552-7556.
5. Dwyer N, Blobel G. 1976. A modified procedure for the isolation of a pore-complex-lamina fraction from rat liver nuclei. J Cell Biol 70:581-591.
6. Enarson P, Rattner JB, Ou Y, et al. 2004. Autoantigens of the nuclear pore complex. J Mol Med 82:423-433.
7. Greber UF, Senior A, Gerace L. 1990. A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J 9:1495-1502.
8. Invernizzi P, Podda M, Battezzati PM, et al. 2001. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366-372.
9. Invernizzi P, Wesierska-Gadek J, Battezzati PM, et al. 2004. Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCs) in early primary biliary cirrhosis (PBC). J Hepatol 40:159-160 (abstract).
10. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. 2005. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298-310.
11. Kaplan MM, Gershwin ME. 2005. Primary biliary cirrhosis. N Engl J Med 353:1261-1273.
12. Kraemer DM, Kraus MR, Kneitz C, et al. 2003. Nucleoporin p62 antibodies in a case of mixed connective tissue disease. Clin Diagn Lab Immunol 10:329-331.
13. Lassoued K, Brenard R, Degos F, Courvalin JC, et al. 1990. Antinuclear antibodies directed to a 200 kDa polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 99:181-186.
14. Lin F, Noyer CM, Ye Q, et al. 1996. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 23:57-61.
15. Lozano F, Pares A, Borsche L, et al. 1988. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 8:930-938.
16. Miyachi K, Shibata M, Onozuka Y, et al. 1996. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Mol Biol Rep 23:227-234.
17. Miyachi K, Hankins RW, Matsushima H, et al. 2003. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: A multicenter study. J Autoimmun 20:247-254.
18. Nakamura M, Kondo H, Mori T, et al. 2007. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118-127.
19. Ou Y, Enarson P, Barr SG, et al. 2004. The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Clin Exp Immunol 136:379-387.
20. Starr CM, Hanover JA. 1990. Glycosylation of nuclear pore protein p62. J Biol Chem 265:6868-6873.
21. Starr CM, D'Onofrio M, Park MK, Hanover JA. 1990. Primary sequence and heterologous expression of nuclear pore glycoprotein p62. J Cell Biol 110:1861-1871.
22. Talwalkar JA, Lindor KDA. 2003. Primary biliary cirrhosis. Lancet 362:53-61.
23. Van der Water J, Cooper A, Surh CD, et al. 1989. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 320:1377-1380.
24. Walker JG, Doniach D, Roitt IM, Sherlock S. 1965. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 39:827-831.
25. Wesierska-Gadek J, Penner E, Hitchman E, et al. 1988. Antibodies to nuclear lamins in autoimmune liver disease. Clin Immunol Immunopathol 49:107-115.
26. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. 1995. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med 182:1159-1162.
27. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. 1996a. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110:840-847.
28. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. 1996b. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kDa fragment of gp210 as a major epitope. Hum Antibodies Hybridomas 7:167-174.
29. Wesierska-Gadek J, Wojciechowski J, Schmid G. 2003. Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1. J Cell Biochem 89:220-232.
30. Wesierska-Gadek J, Wojciechowski J, Schmid G. 2005. Advantage of baculovirus expression system. Acta Biochim Pol 52:713-719.
31. Wesierska-Gadek J, Penner E, Battezzati PM, et al. 2006. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43:1135-1144.
32. Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. 2007a. Characterization of autoantibodies against components of the nuclear pore complexes. High frequency of anti-p62 nucleoporin antibodies. Annals N Y Acad Sci 1109: (in press).
33. Wesierska-Gadek J, Schmitz ML, Ranftler C. 2007b. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells. J Cell Biochem 100:865-874.
34. Wozniak RW, Bartnik E, Blobel G. 1989. Primary structure analysis of an integral membrane glycoprotein of the nuclear pore. J Cell Biol 108:2083-2092.